Our findings contribute to the better understanding of ApoE, in particular the major genetic risk factor for AD ApoE4, in synaptic and neuronal network dysfunction during early stages of AD and may help provide new insights for future AD therapeutics based on ApoE4 and neuronal dysfunction. Here, APOE is linked to Alzheimer disease.